Overview

Castration With Abiraterone 250 mg Without LHRH Analogs or Blockers in Patients With Prostate Cancer Requiring Hormonal Intensification (Multicenter Phase 2)

Status:
RECRUITING

Trial end date:
2027-03-30

Target enrollment:

Participant gender:

Summary

Hypothesis The use of Abiraterone 250 mg with food + prednisone, without LHRH analogs or blockers (ADT), achieves castration-level testosterone at 30 days in 80-90% of cases.

Phase:

PHASE2

Details

Lead Sponsor:

SMED Clinical Research

Treatments:

abiraterone
Food
Prednisone